In CRC, lomerizine 2HCl, a drug initially used for migraine alleviation, has been shown to suppress the PI3K/AKT/mTOR pathway, leading to decreased protective autophagy and reduced apoptosis. The gene discussed is AKT1; the disease is colorectal carcinoma.